Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study

British Journal of Haematology

Volumn 143, Issue 1, 2008, Pages 39-45

  Del Río Garma, Julio ^a   Alvarez Larrán, Alberto ^b   Martínez, Clara ^c   Muncunill, Josep ^d   Castellà, Dolors ^e   De La Rubia, Javier ^f   Zamora, Concepción ^g   Corral, Mercedes ^h   Viejo, Aurora ⁱ   Peña, Francisco ^j   Rodríguez Vicente, Pilar ^k   Contreras, Enric ^l   Arbona, Cristina ^m   Ramírez, Consuelo ⁿ   Garcia Erce, José A ^o   Alegre, Adrián ^p   Mateo, José ^c   Pereira, Arturo ^q  

^a Service of Haematology   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j HOSPITAL DO MEIXOEIRO   (Spain)

^k HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^l HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^m HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁿ HOSPITAL JUAN CANALEJO   (Spain)

^o HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^p HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^q HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

ADAMTS13; Methylene blue photoinactivated plasma; Plasma exchange; Thrombotic thrombocytopenic purpura

Indexed keywords

CORTICOSTEROID; FRESH FROZEN PLASMA; METHYLENE BLUE; METHYLENE BLUE PHOTOINACTIVATED PLASMA; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMA; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LIGHT; LOGISTIC MODELS; MALE; METHYLENE BLUE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; PROSPECTIVE STUDIES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51249088766     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07292.x     Document Type: Article

References (34)

1. Alvarez-Larrán, A., Del Rio, J., Ramirez, C., Albo, C., Pena, F., Campos, A., Cid, J., Muncunill, J., Sastre, J.L., Sanz, C. Pereira, A. (2004) Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sanguinis, 86, 246 251.
2. Bianchi, V., Robles, R., Alberio, L., Furlan, M. Lammle, B. (2002) Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood, 100, 710 713.
3. Cardigan, R., Allford, S. Williamson, L. (2002) Levels of von Willebrand factor-cleaving protease are normal in methylene blue-treated fresh-frozen plasma. British Journal of Haematology, 117, 253 254.
4. Coppo, P., Bengoufa, D., Veyradier, A., Wolf, M., Bussel, A., Millot, G.A., Malot, S., Heshmati, F., Mira, J.P., Boulanger, E., Galicier, L., Durey-Dragon, M.A., Fremeaux-Bacchi, V., Ramakers, M., Pruna, A., Bordessoule, D., Gouilleux, V., Scrobohaci, M.L., Vernant, J.P., Moreau, D., Azoulay, E., Schlemmer, B., Guillevin, L. Lassoued, K. (2004) Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore), 83, 233 244.
5. Council of Europe (2007) Plasma, fresh frozen (FFP). In:Guide to the Preparation, Use and Quality Assurance of Blood (ed. by Council of Europe publishing pp. 157 161. Council of Europe Publishing, Strasbourg, France.
6. Freedman, B. (1987) Equipoise and the ethics of clinical research. New England Journal of Medicine, 317, 141 145.
7. Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. Lammle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 1578 1584.
8. Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lammle, B. Furlan, M. (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 1386 1389.
9. Haubelt, H., Blome, M., Kiessling, A.H., Isgro, F., Bach, J., Saggau, W. Hellstern, P. (2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sanguinis, 82, 9 14.
10. Hellstern, P. (2004) Solvent/detergent-treated plasma: composition, efficacy, and safety. Current Opinion in Hematology, 11, 346 350.
11. Henon, P. (1991) Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study. Presse Medicale, 20, 1761 1767.
12. Henschen-Edman, A.H. (1997) Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion. Cellular and Molecular Life Sciences, 53, 29 33.
13. Horowitz, M.S. Pehta, J.C. (1998) SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis, 74 (Suppl. 1 231 235.
14. Inada, Y., Hessel, B. Blomback, B. (1978) Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochimica et Biophysica Acta, 532, 161 170.
15. Lambrecht, B., Mohr, H., Knuver-Hopf, J. Schmitt, H. (1991) Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sanguinis, 60, 207 213.
16. McCarthy, L.J., Danielson, C.F., Rothenberger, S.S., Parker, C., Weidner, J., Miraglia, C., Matus, D. Waxman, D. (2000) Completely converting a blood service region to the use of safer plasma. Transfusion, 40, 1264 1267.
17. Mintz, P.D., Neff, A., MacKenzie, M., Goodnough, L.T., Hillyer, C., Kessler, C., McCrae, K., Menitove, J.E., Skikne, B.S., Damon, L., Lopez-Plaza, I., Rouault, C., Crookston, K.P., Benjamin, R.J., George, J., Lin, J.S., Corash, L. Conlan, M.G. (2006) A randomized, controlled phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion, 46, 1693 1704.
18. Murphy, K., O'Brien, P. O'Donnell, J. (2003) Acquired protein S deficiency in thrombotic thrombocytopenic purpura patients receiving solvent/detergent plasma exchange. British Journal of Haematology, 122, 518 519.
19. Pereira, A. (2007) Viral safety measures of plasma for transfusion and applicability in Spain. Medicina clínica, 129, 458 468.
20. Pereira, A., Mazzara, R., Monteagudo, J., Sanz, C., Puig, L., Martinez, A., Ordinas, A. Castillo, R. (1995) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Annals of Hematology, 70, 319 323.
21. Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C. Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura Canadian Apheresis Study Group. New England Journal of Medicine, 325, 393 397.
22. Rock, G., Porta, C. Bobbio-Pallavicini, E. (2000) Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica, 85, 410 419.
23. Rose, M. Eldor, A. (1987) High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. American Journal of Medicine, 83, 437 444.
24. de la Rubia, J., Arriaga, F., Linares, D., Larrea, L., Carpio, N., Marty, M.L. Sanz, M.A. (2001) Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 114, 721 723.
25. Shim, K., Anderson, P.J., Tuley, E.A., Wiswall, E. Evan, S.J. (2008) Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood, 111, 651 657.
26. Singh, Y., Sawyer, L.S., Pinkoski, L.S., Dupuis, K.W., Hsu, J.C., Lin, L. Corash, L. (2006) Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion, 46, 1168 1177.
27. Solheim, B.G. Seghatchian, J. (2006) Update on pathogen reduction technology for therapeutic plasma: an overview. Transfusion and Apheresis Science, 35, 83 90.
28. Vesely, S.K., George, J.N., Lammle, B., Studt, J.D., Alberio, L., El-Harake, M.A. Raskob, G.E. (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood, 102, 60 68.
29. Veyradier, A., Obert, B., Houllier, A., Meyer, D. Girma, J.P. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood, 98, 1765 1772.
30. Williamson, L.M., Cardigan, R. Prowse, C.V. (2003) Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion, 43, 1322 1329.
31. Wollowitz, S. (2001) Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Seminars in Hematology, 38, 4 11.
32. Wyllie, B.F., Garg, A.X., Macnab, J., Rock, G.A. Clark, W.F. (2006) Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. British Journal of Haematology, 132, 204 209.
33. Yarranton, H., Lawrie, A.S., Purdy, G., Mackie, I.J. Machin, S.J. (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfusion Medicine, 14, 39 44.
34. Zeiler, T., Riess, H., Wittmann, G., Hintz, G., Zimmermann, R., Muller, C., Heuft, H.G. Huhn, D. (1994) The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion, 34, 685 689.